156 related articles for article (PubMed ID: 36926353)
21. Irreversible electroporation of locally advanced pancreatic neck/body adenocarcinoma.
Martin RC
J Gastrointest Oncol; 2015 Jun; 6(3):329-35. PubMed ID: 26029461
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report.
Bagla S; Papadouris D
J Vasc Interv Radiol; 2012 Jan; 23(1):142-5. PubMed ID: 22221480
[TBL] [Abstract][Full Text] [Related]
23. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
[TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation in a case of pancreatic leiomyosarcoma: a novel weapon versus a rare malignancy?
Papalampros A; Vailas MG; Deladetsima I; Moris D; Sotiropoulou M; Syllaios A; Petrou A; Felekouras E
World J Surg Oncol; 2019 Jan; 17(1):6. PubMed ID: 30611280
[TBL] [Abstract][Full Text] [Related]
25. Irreversible electroporation for locally advanced pancreatic cancer.
Tasu JP; Vesselle G; Herpe G; Richer JP; Boucebci S; Vélasco S; Carretier M; Debeane B; Tougeron D
Diagn Interv Imaging; 2016 Dec; 97(12):1297-1304. PubMed ID: 27856215
[TBL] [Abstract][Full Text] [Related]
26. Irreversible Electroporation for Locally Advanced Pancreatic Cancer: Where Do We Stand in 2017?
Tasu JP; Vesselle G; Herpe G; Richer JP; Boucecbi S; Vélasco S; Debeane B; Carretier M; Tougeron D
Pancreas; 2017 Mar; 46(3):283-287. PubMed ID: 28187107
[TBL] [Abstract][Full Text] [Related]
27. Arterial complication of irreversible electroporation procedure for locally advanced pancreatic cancer.
Ekici Y; Tezcaner T; Aydın HO; Boyvat F; Moray G
World J Gastrointest Oncol; 2016 Oct; 8(10):751-756. PubMed ID: 27795815
[TBL] [Abstract][Full Text] [Related]
28. Imaging in staging and management of pancreatic ductal adenocarcinoma.
Vikram R; Balachandran A
Indian J Surg Oncol; 2011 Jun; 2(2):78-87. PubMed ID: 22693399
[TBL] [Abstract][Full Text] [Related]
29. Spiral computed tomography assessment of resectability of pancreatic ductal adenocarcinoma: analysis of results.
Procacci C; Biasiutti C; Carbognin G; Bicego E; Graziani R; Franzoso F; Pesci A; Megibow AJ
Dig Liver Dis; 2002 Oct; 34(10):739-47. PubMed ID: 12469802
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience.
Belfiore MP; Ronza FM; Romano F; Ianniello GP; De Lucia G; Gallo C; Marsicano C; Di Gennaro TL; Belfiore G
Int J Surg; 2015 Sep; 21 Suppl 1():S34-9. PubMed ID: 26118600
[TBL] [Abstract][Full Text] [Related]
31. Irreversible electroporation of stage 3 locally advanced pancreatic cancer: optimal technique and outcomes.
Martin RCG
J Vis Surg; 2015; 1():4. PubMed ID: 29075594
[TBL] [Abstract][Full Text] [Related]
32. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
[TBL] [Abstract][Full Text] [Related]
34. Stage III pancreatic cancer and the role of irreversible electroporation.
Al Efishat M; Wolfgang CL; Weiss MJ
BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
[TBL] [Abstract][Full Text] [Related]
36. Interventional Radiology in the Treatment of Pancreatic Adenocarcinoma: Present and Future Perspectives.
Punzi E; Carrubba C; Contegiacomo A; Posa A; Barbieri P; De Leoni D; Mazza G; Tanzilli A; Cina A; Natale L; Sala E; Iezzi R
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983990
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment of hepatic oligometastatic pancreatic ductal adenocarcinoma: An analysis of the National Cancer Database.
Hamad A; Underhill J; Ansari A; Thayaparan V; Cloyd JM; Li Y; Pawlik TM; Tsung A; Abushahin L; Ejaz A
Surgery; 2022 Jun; 171(6):1464-1470. PubMed ID: 35115154
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol.
Venkat S; Hosein PJ; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic ductal adenocarcinoma: ultrasound, computed tomography, and magnetic resonance imaging features.
Tamm EP; Bhosale PR; Lee JH
Semin Ultrasound CT MR; 2007 Oct; 28(5):330-8. PubMed ID: 17970550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
